Source: PR NEWSWIRE

Press Release: Machaon Diagnostics : New Test Offers Genetic Confirmation for Atypical Hemolytic Uremic Syndrome in 48 Hours

OAKLAND, Calif., March 31, 2014 /PRNewswire/ -- Machaon Diagnostics today announced the availability of its "aHUS Genetic Panel™" (patent pending) to genetically confirm atypical Hemolytic Uremic Syndrome (aHUS) with a turnaround time of 48 hours. The 48 hour timeframe is a...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Michael Ero's photo - Founder & CEO of Machaon Diagnostics

Founder & CEO

Michael Ero

CEO Approval Rating

85/100

Read more